ATE461709T1 - Choline-bindende proteine derivate aus pneumokoken als impfstoff - Google Patents

Choline-bindende proteine derivate aus pneumokoken als impfstoff

Info

Publication number
ATE461709T1
ATE461709T1 AT99915326T AT99915326T ATE461709T1 AT E461709 T1 ATE461709 T1 AT E461709T1 AT 99915326 T AT99915326 T AT 99915326T AT 99915326 T AT99915326 T AT 99915326T AT E461709 T1 ATE461709 T1 AT E461709T1
Authority
AT
Austria
Prior art keywords
choline
pneumococes
vaccines
binding proteins
provides
Prior art date
Application number
AT99915326T
Other languages
English (en)
Inventor
Theresa Wizemann
Scott Koenig
Leslie Johnson
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Application granted granted Critical
Publication of ATE461709T1 publication Critical patent/ATE461709T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT99915326T 1998-04-07 1999-04-06 Choline-bindende proteine derivate aus pneumokoken als impfstoff ATE461709T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US8574398P 1998-05-15 1998-05-15
PCT/US1999/007680 WO1999051266A2 (en) 1998-04-07 1999-04-06 Derivatives of pneumococcal choline binding proteins for vaccines

Publications (1)

Publication Number Publication Date
ATE461709T1 true ATE461709T1 (de) 2010-04-15

Family

ID=26764078

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99915326T ATE461709T1 (de) 1998-04-07 1999-04-06 Choline-bindende proteine derivate aus pneumokoken als impfstoff

Country Status (16)

Country Link
US (3) US6503511B1 (de)
EP (1) EP1067962B1 (de)
JP (1) JP2002510649A (de)
KR (2) KR20060126844A (de)
CN (1) CN1200731C (de)
AT (1) ATE461709T1 (de)
AU (1) AU766455C (de)
BR (1) BR9909483A (de)
CA (1) CA2325340A1 (de)
DE (1) DE69942176D1 (de)
ES (1) ES2343492T3 (de)
HU (1) HUP0102617A3 (de)
IL (2) IL138798A0 (de)
NO (1) NO20004972L (de)
NZ (2) NZ507717A (de)
WO (1) WO1999051266A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
IL138939A0 (en) * 1998-04-07 2001-11-25 St Jude Childrens Res Hospital A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
US6503511B1 (en) * 1998-04-07 2003-01-07 Medimmune, Inc. Derivatives of choline binding proteins for vaccines
US20010016200A1 (en) 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
KR100642044B1 (ko) 1999-03-19 2006-11-10 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
US20040091495A1 (en) * 2000-07-20 2004-05-13 Lars Bjorck Protein
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
US6674504B1 (en) 2000-09-29 2004-01-06 Kent Optronics, Inc. Single layer multi-state ultra-fast cholesteric liquid crystal device and the fabrication methods thereof
DE20321889U1 (de) 2002-08-02 2012-03-12 Glaxosmithkline Biologicals S.A. Impfstoffzusammensetzung
DK1556477T3 (en) 2002-11-01 2017-10-23 Glaxosmithkline Biologicals Sa Process for drying
ATE474595T1 (de) 2003-10-02 2010-08-15 Glaxosmithkline Biolog Sa B. pertussis antigene und ihre verwendung bei der vakzinierung
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
CN103251940A (zh) 2005-12-22 2013-08-21 葛兰素史密丝克莱恩生物有限公司 疫苗
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
SG10201600336RA (en) 2006-01-17 2016-02-26 Arne Forsgren A novel surface exposed haemophilus influenzae protein (protein e; pe)
US8722055B2 (en) * 2006-09-27 2014-05-13 St. Jude Children's Research Hospital Synthetic Streptococcus pneumoniae vaccine
MX2009013949A (es) 2007-06-26 2010-05-24 Glaxosmithkline Biolog Sa Vacuna que comprende conjugados de polisacárido capsular de streptococcus pneumoniae.
JP5056490B2 (ja) * 2008-03-10 2012-10-24 富士通株式会社 歪み補償係数更新装置および歪み補償増幅器
MX2010011412A (es) 2008-04-16 2010-11-12 Glaxosmithkline Biolog Sa Vacuna.
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
JP2013521326A (ja) 2010-03-10 2013-06-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
EP3351641A1 (de) 2011-04-08 2018-07-25 Tufts Medical Center, Inc. Pepducin-design und -verwendung
US20140072622A1 (en) 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
JP2014000016A (ja) * 2012-06-15 2014-01-09 National Agriculture & Food Research Organization 豚丹毒菌の新規な抗原タンパク質、その遺伝子、及び組換えベクターとその利用
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
ES2984663T3 (es) 2015-11-13 2024-10-30 Oasis Pharmaceuticals Llc Moduladores del receptor 2 activados por proteasa
EP3634481A4 (de) 2017-06-10 2021-07-21 Inventprise, LLC. Multivalente konjugatimpfstoffe mit bivalenten oder multivalenten konjugierten polysacchariden, die verbesserte immunogenität und avidität bereitstellen
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
GB201714478D0 (en) * 2017-09-08 2017-10-25 Univ Bristol Sensor
WO2022035816A1 (en) 2020-08-10 2022-02-17 Inventprise, Llc Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232116B1 (en) * 1991-02-15 2001-05-15 University Of Alabama At Birmingham Research Foundation Oral administration of pneumococcal antigens
US6231870B1 (en) * 1995-06-02 2001-05-15 Uab Research Foundation Oral administration of pneumoccal antigens
US5980909A (en) * 1991-02-15 1999-11-09 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
US6042838A (en) * 1991-02-15 2000-03-28 Uab Research Foundation immunogenic compositions for mucosal administration of pneumococcal surface protein A (PspA)
US6027734A (en) * 1991-02-15 2000-02-22 Uab Research Foundation Mucosal administration of pneumococcal antigens
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
EP0912608B1 (de) * 1996-05-01 2006-04-19 The Rockefeller University Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
US6245335B1 (en) * 1996-05-01 2001-06-12 The Rockefeller University Choline binding proteins for anti-pneumococcal vaccines
PT942983E (pt) * 1996-10-31 2007-02-28 Human Genome Sciences Inc Antigénios e vacinas de streptococcus pneumoniae
CA2270898A1 (en) * 1996-11-06 1998-05-14 The Regents Of The University Of California Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof
EP0942984A2 (de) * 1996-11-12 1999-09-22 Regents Of The University Of Minnesota C3 bindendes protein aus streptococcus pneumoniae
DE19708537A1 (de) 1997-03-03 1998-09-10 Biotechnolog Forschung Gmbh Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
US7018637B2 (en) * 1998-02-23 2006-03-28 Aventis Pasteur, Inc Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
US6503511B1 (en) * 1998-04-07 2003-01-07 Medimmune, Inc. Derivatives of choline binding proteins for vaccines
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
US6936252B2 (en) * 1998-07-27 2005-08-30 Microbial Technics Limited Streptococcus pneumoniae proteins and nucleic acid molecules
DK1140157T3 (da) * 1998-12-21 2009-06-08 Medimmune Inc Streptococcus pneumoniae-proteiner og immunogene fragmenter til vacciner
JP2003530872A (ja) * 2000-04-27 2003-10-21 メディミューン，インコーポレイテッド 免疫原肺炎連鎖球菌タンパク質とそのワクチン組成物
EP2921924B1 (de) * 2014-03-21 2018-09-19 Asco Numatics GmbH Vorrichtung zur Bereitstellung eines Fluids mit geregeltem Ausgangsdruck
US9741151B2 (en) * 2015-04-14 2017-08-22 International Business Machines Corporation Mobile interactive comparison chart

Also Published As

Publication number Publication date
US6503511B1 (en) 2003-01-07
HUP0102617A3 (en) 2006-04-28
EP1067962B1 (de) 2010-03-24
HUP0102617A2 (hu) 2001-11-28
CN1315870A (zh) 2001-10-03
ES2343492T3 (es) 2010-08-02
WO1999051266A2 (en) 1999-10-14
CN1200731C (zh) 2005-05-11
NZ530277A (en) 2005-08-26
CA2325340A1 (en) 1999-10-14
IL138798A (en) 2008-11-03
KR20010034752A (ko) 2001-04-25
NO20004972L (no) 2000-12-05
DE69942176D1 (de) 2010-05-06
AU766455B2 (en) 2003-10-16
US7435421B2 (en) 2008-10-14
JP2002510649A (ja) 2002-04-09
KR100794394B1 (ko) 2008-01-15
US20050142145A1 (en) 2005-06-30
US6863893B2 (en) 2005-03-08
BR9909483A (pt) 2001-10-09
IL138798A0 (en) 2001-10-31
KR20060126844A (ko) 2006-12-08
NZ507717A (en) 2004-02-27
EP1067962A2 (de) 2001-01-17
US20030138447A1 (en) 2003-07-24
NO20004972D0 (no) 2000-10-03
AU766455C (en) 2004-12-02
AU3386999A (en) 1999-10-25
WO1999051266A3 (en) 1999-12-09

Similar Documents

Publication Publication Date Title
ATE461709T1 (de) Choline-bindende proteine derivate aus pneumokoken als impfstoff
WO2002004496A3 (en) Fimh adhesin proteins and methods of use
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
WO2002102974A3 (en) Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
EA200201280A1 (ru) Стрептококковые антигены
NZ512574A (en) Novel streptococcus antigens useful as vaccines
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
PT815235E (pt) Vacinas para peste
BR0316758A (pt) Vacinas baseadas em levedura como imunoterapia
DE602004013993D1 (de) R für biologische wirksubstanz zur oralen verabreichung
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
DE602004028029D1 (en) Rwendung
BR0109928A (pt) Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal
NO20041564L (no) Infeksios lakse anemi-virus vaksine
ATE367806T1 (de) Mittel und verfahren zur vorbeugung von durch chemotherapie ausgelöster alopezie
JP2010516279A (ja) 表皮ブドウ球菌に対する防御免疫応答を誘導するためのポリペプチド
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
CA2382336A1 (en) Vaccines from infectious agents
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
AU5489500A (en) Isolation of a human retrovirus
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
CY1108761T1 (el) Απενεργοποιημενες κυτοκινες για ανοσοποιηση
WO2024130155A3 (en) Swine influenza vaccine compositions and methods thereof
Shewen Department of Veterinary Microbiology and Immunology Ontario Veterinary College University of Guelph Guelph, Canada N1G 2W1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties